Improved method for measuring C1-r-C1-s-(C1 inh)2 complexes by an enzyme-linked immunosorbent assay.
Improved method for measuring C1-r-C1-s-(C1 inh)2 complexes by an enzyme-linked immunosorbent assay.
复制标题
通过酶联免疫吸附测定测量 C1-r-C1-s-(C1 inh)2 复合物的改进方法。
DOI:
10.1002/jcla.1860090309
复制
发表时间:
1995
影响因子:
2.7
通讯作者:
Zuraw,BL
中科院分区:
文献类型:
--
作者:
Mathews,KP;Herschbach,JH;Chambers,SL;Zuraw,BL
Measurement of C1rC1s‐(C1 inh)2complexes in serum or plasma by enzyme‐linked immunosorbent assay (ELISA) has been proposed as a relatively convenient and sensitive means for assessing C1 activation. However, interference by unactivated C1 q (r‐s)2at low serum or plasma dilutions has resulted in estimates that vary widely with the degree of serum or plasma dilution. Precipitating the interfering C1q (r‐s)2with 6% polyethylene glycol has been proposed to resolve this problem, but here it is shown that this procedure also precipitates or coprecipitates some of the C1rC1s‐C1rC1s‐(C1 inh)2complexes. Satisfactory results have been achieved without PEG precipitation by testing high plasma dilutions under conditions where there is a sufficient excess of anti‐C1s coating the microtitration plate wells that removal of C1q (r‐s)2is not necessary. Optimizing conditions for quantitating these complexes at high dilution have been investigated. The mean normal EDTA plasma C1rC1s‐C1rC1s‐(C1 inh)2complex measurement was 36.6±7.0 (S.D.) ELISA units with a 95% confidence interval of 19.5–47.6u. Besides providing a sensitive assay for C1 activation, measuring C1rC1s‐C1rC1s‐(C1 inh)2complexes may help to clarify the pathophysiologic mechanisms resulting from C1 inh deficiency under various conditions.©1995 wiley‐Liss, inc.